AeviceMD for Detection of Wheeze in Pediatric and Adult Populations
A Pilot Study to Assess Aevice Medical Device for Detection of Wheeze in Pediatric and Adult Populations
Who can join
Ages 3 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * The subject is willing and/or parents/guardians are able to give informed consent for participation in the study. * Male or Female, aged ≥ 3 years. * Diagnosed with acute asthma exacerbation by an ED provider. Exclusion Criteria: * Any other significant disease or disorder which, in the opinion of the Investigator, may either put the subjects at risk because of participation in the study, or may influence the result of the study, or the subject's ability to participate in the study.
About the study
Respiratory signs and symptoms consisting of wheeze, cough, and breathlessness are obtained in a manual fashion through history taking and physical examination by the healthcare professional. Auscultation of the lung assesses airflow through the trachea-bronchial tree and is helpful in diagnosing various respiratory disorders. AeviceMD is a wearable device that can acquire and process lung sounds, thus assisting in the detection of abnormal lung sounds. The primary objective of this study is to determine if AeviceMD can detect wheeze of pediatrics and adults as accurately as a physician through auscultation. The secondary objective is to investigate if AeviceMD can be used for remote auscultation of breath sounds.
What is being tested
- AeviceMD (device)
Sponsor: Aevice Health Pte. Ltd. · Participants: 160 · Started: Jun 29, 2023
Contact the study team
- Sunit P. Jariwala, Professor, M.D. · Phone: 718-920-6089
- Carlos L. Lutz, Assistant Professor, M.D. · Phone: 718-920-6626
Official record on ClinicalTrials.gov — NCT06691971
Locations in the U.S.
| New York | Montefiore Medical Center, The Bronx |
Conditions
From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.